American Cannabis Operator Index Outperforms the Broad Sector Once more – New Cannabis Ventures


The American Cannabis Operator Index fell once again for the eighth consecutive month but managed to outperform the broader cannabis sector once again, declining six.9% to 44.22:

In Q4, the index has declined 12.six% compared to a sharper drop in the Worldwide Cannabis Stock Index, which has declined 21.9% on the back of weakness amongst Canadian licensed producers. The index, which launched at the finish of October 2018 with a worth of 100, reached a closing higher of 124.16 a week later prior to declining to 70.64 in late December. In 2019, it rallied as higher as 119.53 in early April prior to promoting off more than the balance of the year. This previous month, it ended 7.two% above the 2019 low set on November 19th at 41.27 and is now down 42.eight% in 2019:

Throughout November, the index integrated 23 providers, which includes 19 multi-state operators (MSOs) and four focused solely on CBD extracted from industrial hemp. Many MSOs are pursuing CBD methods apart from their state-licensed cannabis corporations. 7 providers managed double-digit gains, though 11 posted double-digit losses, which includes six that lost far more than 25% of their worth:

The 4 finest performing stocks have been TILT Holdings (CSE: TILT) (OTC: TLLTF), Trulieve (CSE: TRUL) (OTC: TCNNF), Curaleaf Holdings (CSE: CURA) (OTC: CURLF) and Liberty Wellness Sciences (CSE: LHS) (OTC: LHSIF). TILT Holdings reported Q3 income of C$46.1 million with enhanced profitability and was capable to raise capital throughout the month. Trulieve maintained its position as the MSO with the major income at $70.7 million as it delivered substantial operating earnings. Curaleaf Holdings saw Q3 income jump 27% sequentially to $61.eight million. Liberty  extended gains from final month, when it reported fiscal Q2 financials that showed 93% sequential income development and enhanced profitability.

The 4 worst performing stocks have been MedMen (CSE: MMEN) (OTC: MMNFF), CV Sciences (OTC: CVSI), Elixinol Worldwide (ASX: ELLXF) (OTC: ELLXF) and MariMed (OTC: MRMD). MedMen plunged  mid-month following announcing layoffs and a program to reach profitability. Its fiscal Q1 showed sequential income development of only five% as losses declined only modestly. CV Sciences and Elixinol Worldwide suffered from income declines in Q3 as properly as the FDA statement relating to CBD security late in the month. MariMed was late to file its financials but did so as the month ended, with income falling sharply from the prior quarter.

For December, the quantity of names in the index will stay at 23.  Elixinol Worldwide, Plus Solutions (CSE: PLUS) OTC: PLPRF) and SLANG Worldwide (CSE: SLNG) (OTC: SLGWF) have been removed due to not meeting the trading volume requirement, though Halo Labs (NEO: HALO) (OTC: AGEEF) and Vireo Wellness (CSE: VREO) (OTC: VREOF) return and Flower 1 (CSE: FONE) (OTC: FLOOF) joins for the initially time.

In the subsequent month-to-month assessment, we will summarize the functionality for December and talk about any additions or deletions. Be positive to bookmark the web page to keep present on American cannabis operators stock price tag movements inside the day or from day-to-day.

Get ahead of the crowd by signing up for 420 Investor, the biggest &amp most extensive premium subscription service for cannabis traders and investors considering the fact that 2013.

Alan Brochstein, CFA
Primarily based in Houston, Alan leverages his knowledge as founder of on the internet communities 420 Investor, the initially and nevertheless biggest due diligence platform focused on the publicly-traded stocks in the cannabis sector. With his in depth network in the cannabis neighborhood, Alan continues to come across new strategies to connect the sector and facilitate its sustainable development. At New Cannabis Ventures, he is accountable for content material improvement and strategic alliances. Just before shifting his concentrate to the cannabis sector in early 2013, Alan, who started his profession on Wall Street in 1986, worked as an independent study analyst following more than two decades in study and portfolio management. A prolific writer, with more than 650 articles published considering the fact that 2007 at Looking for Alpha, exactly where he has 70,000 followers, Alan is a frequent speaker at sector conferences and a frequent supply to the media, which includes the NY Instances, the Wall Street Journal, Fox Company, and Bloomberg Television. Speak to Alan: Twitter | Facebook | LinkedIn | E-mail

Get Our Sunday Newsletter

&#13 &#13


Latest posts